12
Participants
Start Date
February 28, 2011
Primary Completion Date
February 29, 2012
Study Completion Date
June 30, 2012
Regadenoson
Regadenoson (0.4 mg/5 ml IV) was administered intravenously over 10 seconds, followed immediately by saline flush.
Adenosine
Adenosine (140 μg/kg/min) was administered intravenously over 6 minutes.
N-13 ammonia
Ammonia N-13 Injection is a radioactive diagnostic agent for Positron Emission Tomography (PET) indicated for diagnostic PET imaging of the myocardium under rest or pharmacologic stress conditions to evaluate myocardial perfusion in patients with suspected or existing coronary artery disease. The N-13 ammonia used in the study was synthesized by the Mayo Cyclotron Facility as per routine institutional clinical protocol.
Mayo Clinic, Rochester
Lead Sponsor
Collaborators (1)
Astellas Pharma Inc
INDUSTRY
Mayo Clinic
OTHER